Status:
UNKNOWN
Comparison Of Different Doses Of Intrathecal Neostigmine In Prevention Of Post-Dural Puncture Headache
Lead Sponsor:
Cairo University
Conditions:
Headache
Eligibility:
FEMALE
18-45 years
Phase:
PHASE2
PHASE3
Brief Summary
We hypothesized that; intrathecal administration of neostgmine in spinal anesthesia may have a beneficial role in reduction of the incidence or severity of PDPH.
Detailed Description
Neostigmine will be administered in two different doses (10 \& 20 mic) in addition to 10mg bupivicaine intrathecally for cesarean section compared to control group where 10 mg bupivicaine in addition ...
Eligibility Criteria
Inclusion
- Patients indicated for elective caesarean section surgery
Exclusion
- Contraindications for regional anesthesia including local infection, hemorrhagic disorders, drug hypersensitivity, muscular disorders and central and peripheral neuropathy, and drug abuse history and addiction.
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2022
Estimated Enrollment :
274 Patients enrolled
Trial Details
Trial ID
NCT04905953
Start Date
February 1 2021
End Date
May 1 2022
Last Update
May 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine- Cairo University
Cairo, Egypt, 11562